var title_f26_55_27504="Pneumatic retinopexy";
var content_f26_55_27504=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumatic retinopexy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pneumatic retinopexy involves cryoretinopexy of the retinal break followed by injection of an intravitreal gas bubble.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wilkinson CP, Rice TA. Mitchel's Retinal Detachment, 2nd ed, Mosby-Year Book, Inc., Louis 1997. Copyright &copy; Charles P Wilkinson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27504=[""].join("\n");
var outline_f26_55_27504=null;
var title_f26_55_27505="Handprint";
var content_f26_55_27505=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Handprint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 361px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Stephen Ludwig, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27505=[""].join("\n");
var outline_f26_55_27505=null;
var title_f26_55_27506="Erythrasma biopsy";
var content_f26_55_27506=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythrasma biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hematoxylin and eosin stained slide of erythrasma. Bacteria are visible in the superficial levels of the epidermis. Special stains are often required to appreciate the bacteria in pathology sections.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. James E. Fitzpatrick.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27506=[""].join("\n");
var outline_f26_55_27506=null;
var title_f26_55_27507="Strontium-89: Patient drug information";
var content_f26_55_27507=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Strontium-89: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/14/26851?source=see_link\">",
"     see \"Strontium-89: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F223324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Metastron&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F223325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Metastron&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691759",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bone pain caused by cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702959",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to strontium or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696962",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow what you were told to do by your doctor after leaving the hospital to stop exposing others to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697738",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug and for up to 12 months after this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698167",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More bone pain may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12127 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27507=[""].join("\n");
var outline_f26_55_27507=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223324\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223325\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011690\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011689\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011694\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011695\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011697\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011692\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011698\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011699\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/14/26851?source=related_link\">",
"      Strontium-89: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_55_27508="Skin bx pyoderma gangrenosum";
var content_f26_55_27508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyoderma gangrenosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skin biopsy in pyoderma gangrenosum showing a diffuse neutrophilic infiltrate with dermolysis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27508=[""].join("\n");
var outline_f26_55_27508=null;
var title_f26_55_27509="Pyridostigmine: Drug information";
var content_f26_55_27509=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pyridostigmine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?38/53/39764?source=see_link\">",
"    see \"Pyridostigmine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/3/41013?source=see_link\">",
"    see \"Pyridostigmine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F215907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mestinon&reg;;",
"     </li>",
"     <li>",
"      Mestinon&reg; Timespan&reg;;",
"     </li>",
"     <li>",
"      Regonol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F215908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mestinon&reg;;",
"     </li>",
"     <li>",
"      Mestinon&reg;-SR",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F215948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Acetylcholinesterase Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F215911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Myasthenia gravis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Oral:",
"     </i>",
"     Highly individualized dosing ranges: 60-1500 mg/day, usually 600 mg/day divided into 5-6 doses, spaced to provide maximum relief",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Sustained release formulation: Highly individualized dosing ranges: 180-540 mg once or twice daily (doses separated by at least 6 hours);",
"     <b>",
"      Note:",
"     </b>",
"     Most clinicians reserve sustained release dosage form for bedtime dose only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M. or slow I.V. push:",
"     </i>",
"     To supplement oral dosage pre- and postoperatively during labor and postpartum, during myasthenic crisis, or when oral therapy is impractical): ~1/30th of oral dose; observe patient closely for cholinergic reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. infusion:",
"     </i>",
"     To supplement oral dosage pre- and postoperatively, during labor and postpartum, during myasthenic crisis, or when oral therapy is impractical): Initial: 2 mg/hour with gradual titration in increments of 0.5-1 mg/hour, up to a maximum rate of 4 mg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Reversal of nondepolarizing muscle relaxants:",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     0.1-0.25 mg/kg/dose; 10-20 mg is usually sufficient (full recovery usually occurs &le;15 minutes, but &ge;30 minutes may be required).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Atropine sulfate (0.6-1.2 mg) I.V. immediately prior to pyridostigmine to minimize side effects",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pretreatment for Soman nerve gas exposure (military use):",
"     </b>",
"     <i>",
"      Oral:",
"     </i>",
"     30 mg every 8 hours beginning several hours prior to exposure; discontinue at first sign of nerve agent exposure, then begin atropine and pralidoxime",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F215928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/3/41013?source=see_link\">",
"      see \"Pyridostigmine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Myasthenia gravis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Oral:",
"     </i>",
"     Children: 7 mg/kg/24 hours divided into 5-6 doses. Most clinicians reserve sustained release dosage form for bedtime dose only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M., slow I.V. push:",
"     </i>",
"     Children: 0.05-0.15 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Reversal of nondepolarizing muscle relaxants:",
"     </b>",
"     I.V.: Children: Dosing range: 0.1-0.25 mg/kg/dose (full recovery usually occurs &le;15 minutes, but &ge;30 minutes may be required).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Atropine sulfate (0.6-1.2 mg) I.V. immediately prior to pyridostigmine to minimize side effects:",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F215912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F215913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lower dosages may be required due to prolonged elimination; no specific recommendations have been published.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F215882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as bromide:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Regonol&reg;: 5 mg/mL (2 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral, as bromide:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mestinon&reg;: 60 mg/5 mL (480 mL) [contains ethanol 5%, sodium benzoate; raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as bromide: 60 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mestinon&reg;: 60 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, sustained release, oral, as bromide:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mestinon&reg; Timespan&reg;: 180 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F215867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F215885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     crush sustained release tablet.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F215955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Heparin, hydrocortisone sodium succinate, potassium chloride, vitamin B complex with C.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Glycopyrrolate.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F215884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic treatment of myasthenia gravis; antagonism of nondepolarizing neuromuscular blockers",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Military use: Pretreatment for Soman nerve gas exposure",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F215957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Pyridostigmine may be confused with physostigmine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Regonol&reg; may be confused with Reglan&reg;, Renagel&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F215946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmias (especially bradycardia), AV block, cardiac arrest, decreased carbon monoxide, flushing, hypotension, nodal rhythm, nonspecific ECG changes, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Convulsions, dizziness, drowsiness, dysphonia, headache, loss of consciousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Skin rash, thrombophlebitis (I.V.), urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dysphagia, flatulence, hyperperistalsis, nausea, salivation, stomach cramps, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary urgency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, dysarthria, fasciculations, muscle cramps, myalgia, spasms, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Amblyopia, lacrimation, small pupils",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchial secretions increased, bronchiolar constriction, bronchospasm, dyspnea, laryngospasm, respiratory arrest, respiratory depression, respiratory muscle paralysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylaxis, diaphoresis increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F215888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pyridostigmine, bromides, or any component of the formulation; GI or GU obstruction",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F215871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinesterase insensitivity: For brief or prolonged periods, anticholinesterase insensitivity can develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cholinergic effects: Discontinue if symptoms of excess cholinergic activity (eg, salivation, sweating, urinary incontinence); overdosage may result in cholinergic crisis, which must be distinguished from myasthenic crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Have atropine and epinephrine ready to treat hypersensitivity reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma or bronchospastic disease: Use with extreme caution in patients with asthma or bronchospastic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with bradycardia or cardiac arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI disease: Use with caution in patients with GI disease, including peptic ulcer disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use with caution in patients with hyperthyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Adequate facilities should be available for cardiopulmonary resuscitation when testing and adjusting dose for myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced personnel: Regonol&reg; injection: Contains 1% benzyl alcohol as the preservative; not intended for use in newborns.",
"     <b>",
"      [U.S. Boxed Warning]: Must be administered by trained personnel.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F215875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Acetylcholinesterase Inhibitors may enhance the bradycardic effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Acetylcholinesterase Inhibitors may enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May diminish the therapeutic effect of Acetylcholinesterase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methocarbamol: May diminish the therapeutic effect of Pyridostigmine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Acetylcholinesterase Inhibitors may diminish the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: Acetylcholinesterase Inhibitors may increase the serum concentration of Succinylcholine.  Management: Consider alternatives to this combination due to a risk of prolonged neuromuscular blockade.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F215878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F215891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety has not been established for use during pregnancy. The potential benefit to the mother should outweigh the potential risk to the fetus. When pyridostigmine is needed in myasthenic mothers, giving dose parenterally 1 hour before completion of the second stage of labor may facilitate delivery and protect the neonate during the immediate postnatal state.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F215916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/compatible",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F215892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Neonates of myasthenia gravis mothers may have difficulty in sucking and swallowing (as well as breathing). Neonatal pyridostigmine may be indicated by symptoms (confirmed by edrophonium test).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F215890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Regonol Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/mL (2 mL): $35.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Syrup",
"     </b>",
"     (Mestinon Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg/5 mL (473 mL): $243.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Mestinon Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     180 mg (30): $170.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Mestinon Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $337.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Pyridostigmine Bromide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $59.85",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F215880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for cholinergic reactions, particularly when administered I.V.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F215893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Amygra (PK);",
"     </li>",
"     <li>",
"      Antilon (TW);",
"     </li>",
"     <li>",
"      Astinon (PH);",
"     </li>",
"     <li>",
"      Brostagin (PL);",
"     </li>",
"     <li>",
"      Distinon (IN);",
"     </li>",
"     <li>",
"      Kalymin (BG, DE, EE, RU);",
"     </li>",
"     <li>",
"      Mestinon (AE, AR, AT, AU, BB, BE, BH, BM, BR, BS, BZ, CH, CN, CO, CR, CY, CZ, DK, DO, EG, ES, FI, FR, GB, GH, GR, GT, GY, HK, HN, HR, HU, ID, IE, IL, IQ, IR, IT, JM, JO, KP, KW, LB, LU, LY, MX, MY, NI, NO, OM, PA, PE, PH, PL, PT, PY, QA, SA, SE, SG, SR, SV, SY, TH, TR, TT, TW, TZ, UG, UY, VE, YE, ZM);",
"     </li>",
"     <li>",
"      Mestinon Retard (NL);",
"     </li>",
"     <li>",
"      Pyrimine (TH);",
"     </li>",
"     <li>",
"      Pyrinol (KP);",
"     </li>",
"     <li>",
"      Pyrinon (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F215870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits destruction of acetylcholine by acetylcholinesterase which facilitates transmission of impulses across myoneural junction",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F215887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Oral, I.M.: 15-30 minutes; I.V. injection: 2-5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Oral: Up to 6-8 hours (due to slow absorption); I.V.: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Very poor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 19 &plusmn; 12 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 10% to 20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 1-2 hours; Renal failure: &le;6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (80% to 90% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Dunn MA and Sidell FR, &ldquo;Progress in Medical Defense Against Nerve Agents,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1989, 262(5):649-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27509/abstract-text/2664236/pubmed\" id=\"2664236\" target=\"_blank\">",
"        2664236",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Keeler JR, Hurst CG, and Dunn MA, &ldquo;Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 266(5):693-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27509/abstract-text/2072481/pubmed\" id=\"2072481\" target=\"_blank\">",
"        2072481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Saltis LM, Martin BR, Traeger SM, et al, &ldquo;Continuous Infusion of Pyridostigmine in the Management of Myasthenic Crisis,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      ,1993, 21(6):938-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27509/abstract-text/8504663/pubmed\" id=\"8504663\" target=\"_blank\">",
"        8504663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sidell FR and Borak J, &ldquo;Chemical Warfare Agents: II. Nerve Agents,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1992, 21(7):865-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27509/abstract-text/1610046/pubmed\" id=\"1610046\" target=\"_blank\">",
"        1610046",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9838 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-7288C09AE7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27509=[""].join("\n");
var outline_f26_55_27509=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709378\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215907\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215908\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215948\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215911\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215928\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215912\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215913\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215882\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215867\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215885\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215955\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215884\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215957\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215946\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215888\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215871\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299967\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215875\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215878\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215891\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215916\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215892\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215890\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215880\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215893\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215870\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215887\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9838\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9838|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?38/53/39764?source=related_link\">",
"      Pyridostigmine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/3/41013?source=related_link\">",
"      Pyridostigmine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_55_27510="Midshaft humeral fractures in adults";
var content_f26_55_27510=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Midshaft humeral fractures in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Rebecca Bassett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27510/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/55/27510/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the humerus can occur proximally, at the shaft, or distally. The majority of both proximal and midshaft humerus fractures are nondisplaced and can be treated conservatively (nonsurgically).",
"   </p>",
"   <p>",
"    Nonstress fractures of the midshaft (diaphysis) of the humerus will be reviewed here. Stress fractures of the humeral shaft and proximal humeral fractures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43812?source=see_link\">",
"     \"Stress fractures of the humeral shaft\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29543?source=see_link\">",
"     \"Proximal humeral fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The humerus is the largest bone in the upper extremity. The proximal humerus articulates with the glenoid of the scapula to form the shoulder joint. The muscles and tendons of the rotator cuff, the acromion, and ligamentous attachments such as those between the coracoid process of the scapula and the acromion, serve to both stabilize the glenohumeral articulation and provide for a wide range of motion of the shoulder joint. The distal humerus articulates with the radius and ulna at the elbow.",
"   </p>",
"   <p>",
"    The greater tuberosity, located lateral to the humeral head and on the superior aspect of the humerus, provides the attachment for three of the rotator cuff muscles: supraspinatus, infraspinatus and teres minor. The lesser tuberosity of the humerus is located on the anterior surface of the humerus and provides the attachment for the subscapularis muscle. For the purposes of fracture classification, the lesser tuberosity marks the boundary between the proximal humerus and the midshaft.",
"   </p>",
"   <p>",
"    The humeral shaft supplies the attachment for a number of powerful muscles. The pectoralis major muscle inserts on the proximal shaft while the deltoid muscle attaches to the midshaft. The biceps brachii and triceps muscle groups attach further distally.",
"   </p>",
"   <p>",
"    The tendon of the long head of the biceps brachii muscle passes between the lesser and greater tuberosities as it courses from its origin on the superior portion of the glenoid to its insertion on the radius.",
"   </p>",
"   <p>",
"    The blood supply to the humeral shaft is supplied by the axillary and brachial artery, the latter branches to form the radial and ulnar artery. The vascular supply can be disrupted if there is considerable displacement of shaft fragments.",
"   </p>",
"   <p>",
"    Innervation of the muscles in the posterior compartment of the arm and forearm is provided by the radial nerve. The radial nerve enters the arm medial to the humerus and anterior to the long (medial) head of the triceps muscle and travels inferolaterally, moving around and adjacent to the humeral shaft, in the radial groove. Thus, the radial nerve is susceptible to injury when there is significant displacement of mid to distal humeral shaft fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/1\">",
"     1",
"    </a>",
"    ]. Median and ulnar nerve injuries are uncommon with such fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midshaft humeral fractures account for 1 to 2 percent of all fractures. These fractures occur at any age, but the incidence increases from the fifth decade [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midshaft fractures typically result from trauma such as a direct blow or bending force to the humerus and, less commonly, from a fall on an outstretched hand or elbow. Midshaft fractures may also result from strong muscle contractions such as in high-velocity throwing or arm wrestling. There is some debate whether this occurs solely from a violent muscle contraction or requires an underlying stress fracture associated with the muscle contraction. A study of 90 recreational baseball players with midshaft humeral fractures concluded that these fractures are caused by the accelerated phase of throwing, and can occur in any recreational baseball player who tries to make a hard throw [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SYMPTOMS AND EXAMINATION FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with midshaft humeral fractures typically present with severe arm pain in the area of the mid-arm but may have referred pain to the shoulder or elbow. Swelling and ecchymosis is often apparent shortly after the injury. The presence of abrasions or lacerations should be noted. If medicolegal circumstances warrant and the patient agrees, photographs of the injured arm can be obtained.",
"   </p>",
"   <p>",
"    There is significant tenderness to palpation and crepitus may be noted at the fracture site. Shortening of the upper arm suggests the presence of significant humeral shaft displacement. Careful examination inspection and palpation of the shoulder and elbow are important to assess for other injuries.",
"   </p>",
"   <p>",
"    The initial evaluation of midshaft humerus fractures includes a detailed neurovascular exam of the affected arm, including close surveillance of the radial and ulnar arteries and the function of the radial, median, and ulnar nerves.",
"   </p>",
"   <p>",
"    The radial nerve is the nerve most commonly injured by midshaft humerus fractures. Injury to the radial nerve results in weakness of wrist, finger, and thumb extension and some weakness of elbow supination. Motor function can be tested by giving the &ldquo;thumbs up&rdquo; sign (",
"    <a class=\"graphic graphic_picture graphicRef83560 \" href=\"UTD.htm?39/33/40465\">",
"     picture 1",
"    </a>",
"    ) and testing resisted extension of the thumb (",
"    <a class=\"graphic graphic_picture graphicRef83561 \" href=\"UTD.htm?29/2/29729\">",
"     picture 2",
"    </a>",
"    ). Sensory loss may be present on the dorsum of the hand and is easily tested at the dorsal webspace between the thumb and index finger.",
"   </p>",
"   <p>",
"    Injury to the median nerve is uncommon following midshaft humeral fractures, but, when it occurs, results in weakness of the flexor muscles of the hand and loss sensation on the palmar surface of the thumb and the index and middle fingers. The largest branch and most commonly injured portion of the median nerve is the anterior interosseus nerve. It lacks a sensory component and results in loss of hand and finger flexion. This is best evaluated by having the patient give an &ldquo;OK sign,&rdquo; which tests the flexor pollicis longus (thumb flexion) and flexor digitorum profundus (DIP flexion of the index finger) (",
"    <a class=\"graphic graphic_picture graphicRef52203 \" href=\"UTD.htm?25/33/26142\">",
"     picture 3",
"    </a>",
"    ). Anterior interosseus syndrome results in weakness or flattening of the &ldquo;OK sign&rdquo; due to loss of thumb and index finger flexion (",
"    <a class=\"graphic graphic_picture graphicRef83562 \" href=\"UTD.htm?34/25/35218\">",
"     picture 4",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p>",
"    The ulnar nerve is seldom injured by midshaft humeral fractures. Injury to the ulnar nerve results in dysfunction of the dorsal and palmar interossei and an inability to abduct and adduct the fingers. This can be tested by asking the patient to make the &ldquo;peace sign&rdquo; (",
"    <a class=\"graphic graphic_picture graphicRef83563 \" href=\"UTD.htm?27/52/28480\">",
"     picture 5",
"    </a>",
"    ) and testing the strength of the interossei (",
"    <a class=\"graphic graphic_picture graphicRef83564 \" href=\"UTD.htm?30/50/31521\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographs of the humeral shaft in an anteroposterior and lateral plane are necessary to evaluate the amount of angulation or displacement of the fracture. If a physical exam cannot exclude injury to the shoulder and elbow, radiographs should include those joints as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fracture patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the humeral shaft can be spiral, oblique or transverse. The AO North American classification system sorts each fracture in to three lettered categories (",
"    <a class=\"graphic graphic_figure graphicRef82018 \" href=\"UTD.htm?30/59/31667\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A - Simple fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68279 \" href=\"UTD.htm?2/52/2895\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      B - Wedge fractures",
"     </li>",
"     <li>",
"      C - Complex (comminuted) fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Depending on the location of the humerus shaft fracture, displacement of the proximal and distal fragments can occur.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fractures near the midpoint of the shaft typically assume an apex lateral position. The proximal fragment is pulled laterally by the deltoid, while the distal fragment is pulled medially by the triceps and biceps. Fractures near the midpoint of the shaft are more likely than more proximal or distal fractures to shorten due to the strong pull of the biceps and triceps muscles.",
"     </li>",
"     <li>",
"      Shaft fractures that are located more proximally are angulated apex medially due to the medial pull of the pectoralis major muscle proximally and the lateral pull of the deltoid muscle distally.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review found no evidence from high quality trials to determine the best management for humeral shaft fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/4\">",
"     4",
"    </a>",
"    ]. Based on available evidence and broad clinical experience, approximately 70 to 80 percent of humeral shaft fractures can be treated non-surgically, but some require functional bracing or use of traction for adequate treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/5\">",
"     5",
"    </a>",
"    ]. Physicians without experience using hanging casts and functional braces should refer most patients with humeral shaft fractures for orthopedic consultation and management.",
"   </p>",
"   <p>",
"    Acceptable positioning of the fracture includes less than 20 degrees of anterior or posterior angulation, less than 30 degrees of varus, and less than 1 inch (2.5 cm) of shortening [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/6\">",
"     6",
"    </a>",
"    ]. Fractures that exceed the limits of acceptable alignment should be referred for closed reduction or operative stabilization.",
"   </p>",
"   <p>",
"    Absolute indications for emergent exploration are open fractures and fractures with associated vascular injuries. Other absolute indications for referral include associated articular injuries, and ipsilateral forearm fractures (floating elbow injuries), pathologic fractures and patients with concomitant traumatic fractures. Distal spiral shaft fractures (Holstein Lewis fractures) have a very high association with radial nerve injuries and should be considered for surgical exploration and repair [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Referral is suggested for all shaft fractures associated with radial nerve injuries at presentation. Whether operative intervention is necessary in all cases of radial nerve dysfunction following fracture manipulation is uncertain. Approximately 75 to 90 percent of radial nerve injuries at presentation are neurapraxias and will resolve without intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other relative indications for referral include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transverse fractures that are relatively unstable and at a high risk of shortening",
"     </li>",
"     <li>",
"      Patient noncompliance",
"     </li>",
"     <li>",
"      An obese body habitus that may result in increased varus deformity",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment for transverse fractures and for other (spiral, oblique and comminuted) fractures differs:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Transverse fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transverse fractures do not require traction and can be treated initially with a splint and standard sling. Initial splinting of humeral shaft fractures is commonly accomplished by a coaptation (sugar tong) splint (",
"    <a class=\"graphic graphic_figure graphicRef69310 \" href=\"UTD.htm?5/12/5315\">",
"     figure 2",
"    </a>",
"    ). The splint is applied to the medial aspect of the upper arm in the axilla and extended down around the elbow and up to the deltoid muscle. It should not extend onto the superior aspect of the shoulder or constrain shoulder motion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link&amp;anchor=H12#H12\">",
"     \"Splinting of musculoskeletal injuries\", section on 'Sugar tong splints'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Spiral, oblique, and comminuted fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most spiral, oblique, and comminuted fractures require some degree of traction to accomplish adequate positioning. This can be accomplished by using a coaptation (sugar-tong) splint with a collar and cuff sling, or a hanging cast. Initial immobilization with a splint and collar and cuff sling is preferred to casting if there is substantial swelling present. Use of a hanging cast is appropriate for reducing apex medial, lateral, anterior, or posterior angulation, if there is minimal swelling and the patient can be relied upon to watch for symptoms and signs of constriction by the cast or the appearance of compartment syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Sugar tong splint with collar and cuff sling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The weight of the arm and the plaster coaptation (proximal sugar tong) splint (",
"    <a class=\"graphic graphic_figure graphicRef69310 \" href=\"UTD.htm?5/12/5315\">",
"     figure 2",
"    </a>",
"    ) provide gentle traction when the elbow is unsupported and the cuff is placed at the wrist or distal forearm (",
"    <a class=\"graphic graphic_figure graphicRef68874 \" href=\"UTD.htm?33/29/34270\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Hanging cast",
"    </span>",
"    &nbsp;&mdash;&nbsp;Application of a hanging cast (",
"    <a class=\"graphic graphic_figure graphicRef67819 \" href=\"UTD.htm?20/44/21185\">",
"     figure 4",
"    </a>",
"    ) is similar to that for a long arm cast. The elbow is placed in 90 degrees of flexion and the forearm in a neutral position. The proximal portion of the cast extends 2 cm above the fracture site. The cast should be hung from the neck to the distal forearm with the elbow left unsupported at all times (this requires sleeping sitting upright). The weight of the cast is to be no more than two pounds, which is equivalent to one made from three 4 inch (10 cm) wide and one 3 inch (7.5 cm) rolls of plaster [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjustments to the length of the neck strap and the distal attachment points can be made to adjust for angulation. In order for the hanging cast to provide traction or to provide a force to reduce fracture angulation, the cast must be unsupported except at the attachment point and the patient must be upright at all times. This means sleeping in an upright position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow-up is initiated on a weekly or biweekly basis until radiographic and clinical union have occurred. Typical healing time is 8 to 14 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Transverse humerus shaft fractures",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Functional bracing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A functional brace is the preferred definitive treatment for transverse humerus shaft fractures and most other midshaft fractures. Swelling and mobility at the fracture site typically decrease enough after one to two weeks to allow a functional brace to be applied. Prefabricated braces of various sizes (such as the Sarmiento brace) can be purchased and applied (",
"    <a class=\"graphic graphic_picture graphicRef70631 graphicRef74136 \" href=\"UTD.htm?25/55/26486\">",
"     picture 7A-B",
"    </a>",
"    ). The brace should be tight and should extend above and below the fracture site. Compression around the fracture site can restore proper positioning and may stimulate early osteoblastic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/9\">",
"     9",
"    </a>",
"    ]. A cuff and collar sling can be used if some degree of traction is necessary.",
"   </p>",
"   <p>",
"    Weekly follow-up with serial radiographs ensures adequate healing and confirms appropriate fracture alignment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Rehabilitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within one week, patients start pendulum exercise in the cuff and collar sling. Progression to increased shoulder motion should be according to pain. In most patients the brace can be removed once callous formation is present and the fracture site is stable to manual stress. Aggressive exercises to improve the range of motion of the shoulder, elbow, and hand and to strengthen the muscles of the affected limb should follow. After brace removal, the patient is reevaluated every two weeks until adequate arm function is achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Results with functional bracing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no head-to-head studies comparing hanging casts to functional bracing, most experts will use functional bracing rather than hanging casts if there is no significant shortening or displacement. The results that can be expected from functional bracing for humerus shaft fractures in the following case series are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 107 cases of closed humerus fractures treated with functional bracing, 82 percent of patients had 8 degrees or less of",
"      <span class=\"nowrap\">",
"       varus/valgus",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       anterior/posterior",
"      </span>",
"      angulation after their fractures had healed and rehabilitation was completed [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/10\">",
"       10",
"      </a>",
"      ]. In the few patients with greater angulation, no obvious functional impairment or cosmetic detriment was noted.",
"     </li>",
"     <li>",
"      Another study of 87 patients with humeral shaft fractures treated with functional bracing noted that 86 percent healed with no restrictions in the movement of their shoulder and elbow joints [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/9\">",
"       9",
"      </a>",
"      ]. Subjectively, 95 percent of the patients were content with the functional treatment, 65 percent claimed to be pain free in their daily activities and at work, and 35 percent felt pain only when doing vigorous activities or heavy physical work.",
"     </li>",
"     <li>",
"      A study that included patients with both open and closed midshaft humerus fractures (620 total) who were treated in prefabricated functional braces, reported that 87 percent of patients had less than 16 degrees of varus deformity, and 81 percent had less than 16 degrees anterior angulation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/11\">",
"       11",
"      </a>",
"      ]. Nonunion rates were less than 2 percent in closed fractures, and 98 percent of patients had limitation of shoulder range of motion less than 25 degrees at the time of brace removal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Displaced oblique or spiral humerus shaft fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with oblique or spiral humeral shaft fractures with displacement or shortening can be treated in a hanging cast (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Hanging cast'",
"    </a>",
"    above). Initial follow-up is weekly with radiographs to ensure that no further displacement occurs and acceptable alignment is maintained. The hanging cast can be removed once callous formation is present and the fracture is stable to manual stress.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Rehabilitation following use of hanging cast",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately after removal of the cast, elbow range of motion and arm strengthening should begin. The patient should be followed every two weeks to evaluate progress.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complications associated with humeral shaft fractures are neurovascular compromise and nonunion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Radial nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common neurological complication of humeral shaft fractures is a radial nerve injury. This occurs in 10 to 18 percent of midshaft fractures and is more common is distal shaft fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/6\">",
"     6",
"    </a>",
"    ]. Of these of radial nerve injuries 75 to 90 percent are temporary neurapraxias which resolve in three to four months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/6\">",
"     6",
"    </a>",
"    ]. However referral to an orthopedic surgeon is recommended for treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Nonunion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonunion of humeral shaft fractures should be considered if there is no radiographic evidence of union at three to four months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/6\">",
"     6",
"    </a>",
"    ]. Symptoms of nonunion included continued pain and swelling. Nonunion occurs more commonly in transverse fractures and severely comminuted fractures. It is estimated to occur in two to five percent of humeral shaft fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/6\">",
"     6",
"    </a>",
"    ]. Operative repair is indicated for all humeral shaft nonunions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Return to sport typically will not occur until complete healing at 8 to 12 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27510/abstract/8\">",
"     8",
"    </a>",
"    ]. Low-impact activity, such as stationary biking, can be used to maintain cardiovascular fitness once pain is well controlled. Returning to work is typically easier in a functional brace, which allows for increased mobility, rather than in a hanging cast. Care must be taken to allow for continuous traction in the hanging cast. Return to work that can be accomplished in a functional brace or hanging cast is anticipated in one to two weeks. Patients whose jobs require use of both arms or involve heavy lifting should not return to work until full radiographic healing, range of motion, and strength are achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Humerus shaft fractures are uncommon injuries that typically occur as the result of a direct blow or bending force applied to the upper arm. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial evaluation of the patient with an upper arm injury includes inspection of skin integrity, neurovascular function, deformity, shortening, and is complemented by radiographs. Shoulder radiographs should include at least one view (axillary or scapular-Y) that assures that the humeral head is not dislocated. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Symptoms and examination findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Radiographic findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urgent orthopedic referral is necessary for patients with open fractures, those who present with neurologic or vascular compromise, associated articular injuries, ipsilateral forearm fractures, and fracture-dislocations. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Indications for orthopedic consultation or referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most (70 to 80 percent) of humerus shaft fractures can be treated without surgical intervention. Initial immobilization is usually accomplished with a coaptation (sugar-tong) splint applied to the upper arm. An ordinary sling is used for most cases of transverse fractures. For oblique and spiral fractures that require some traction, a collar and cuff sling is used instead. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physicians experienced in the use of hanging casts to reduce angulated and displaced humerus shaft fractures may choose to use this technique, and application of a hanging cast rather than a coaptation splint may be appropriate for reliable patients with oblique and spiral fractures who do not have excessive swelling at presentation.",
"     </li>",
"     <li>",
"      After the initial swelling has resolved (typically after one to two weeks), a commercially available functional splint may be used for definitive immobilization and is used until adequate callous formation is apparent radiographically and the fracture is stable to manual stress. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Follow-up care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rehabilitation begins within a week of injury. Pendulum exercises for the shoulder are performed in the sling. Once the brace or hanging cast is removed, exercises to strengthen arm and shoulder muscles and restore range of motion are begun.",
"     </li>",
"     <li>",
"      Return to sports or occupations that involve full use of the arm is expected in 8 to 12 weeks but not until callus is present, the fracture site is stable to manual stress, and range of motion has been restored. Return to work that can be accomplished in a functional brace or hanging cast is anticipated in one to two weeks. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Recommendations for return to sport or work'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/1\">",
"      Ekholm R, Adami J, Tidermark J, et al. Fractures of the shaft of the humerus. An epidemiological study of 401 fractures. J Bone Joint Surg Br 2006; 88:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/2\">",
"      Visser CP, Coene LN, Brand R, Tavy DL. Nerve lesions in proximal humeral fractures. J Shoulder Elbow Surg 2001; 10:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/3\">",
"      Ogawa K, Yoshida A. Throwing fracture of the humeral shaft. An analysis of 90 patients. Am J Sports Med 1998; 26:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/4\">",
"      Gosler MW, Testroote M, Morrenhof JW, Janzing HM. Surgical versus non-surgical interventions for treating humeral shaft fractures in adults. Cochrane Database Syst Rev 2012; 1:CD008832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/5\">",
"      Kristiansen B, Angermann P, Larsen TK. Functional results following fractures of the proximal humerus. A controlled clinical study comparing two periods of immobilization. Arch Orthop Trauma Surg 1989; 108:339.",
"     </a>",
"    </li>",
"    <li>",
"     Wheeless' Textbook of Orthopaedics. www.wheelessonline.com (Accessed on November 20, 2004).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/7\">",
"      Pehlivan O. Functional treatment of the distal third humeral shaft fractures. Arch Orthop Trauma Surg 2002; 122:390.",
"     </a>",
"    </li>",
"    <li>",
"     Fracture Management for Primary Care, Eiff P, Hatch R, Calmbach W.  (Eds), Saunders, Philadelphia 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/9\">",
"      Wallny T, Westermann K, Sagebiel C, et al. Functional treatment of humeral shaft fractures: indications and results. J Orthop Trauma 1997; 11:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/10\">",
"      Zagorski, J, Shenkman, J. The management of humerus fractures with prefabricated braces. J Bone Joint Surg 1983; 7:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27510/abstract/11\">",
"      Sarmiento A, Zagorski JB, Zych GA, et al. Functional bracing for the treatment of fractures of the humeral diaphysis. J Bone Joint Surg Am 2000; 82:478.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 221 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-86B232FEE1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27510=[""].join("\n");
var outline_f26_55_27510=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SYMPTOMS AND EXAMINATION FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fracture patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Transverse fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Spiral, oblique, and comminuted fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Sugar tong splint with collar and cuff sling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Hanging cast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Transverse humerus shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Functional bracing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Results with functional bracing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Displaced oblique or spiral humerus shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Rehabilitation following use of hanging cast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Radial nerve injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nonunion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/221\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/221|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/52/2895\" title=\"diagnostic image 1\">",
"      Adult humerus shaft fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/221|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/59/31667\" title=\"figure 1\">",
"      Classification of humeral shaft fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/12/5315\" title=\"figure 2\">",
"      Proximal sugar tong splint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/29/34270\" title=\"figure 3\">",
"      Collar and cuff sling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/44/21185\" title=\"figure 4\">",
"      Hanging arm cast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/221|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/33/40465\" title=\"picture 1\">",
"      Thumbs up sign for radial nerve motor function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/2/29729\" title=\"picture 2\">",
"      Thumb extension against resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/33/26142\" title=\"picture 3\">",
"      OK sign to assess median nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/25/35218\" title=\"picture 4\">",
"      Weak OK sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/52/28480\" title=\"picture 5\">",
"      Peace sign to assess ulnar nerve motor function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/50/31521\" title=\"picture 6\">",
"      Resisted peace sign for ulnar nerve motor function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/25/18832\" title=\"picture 7A\">",
"      Functional upper arm brace",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/28/10690\" title=\"picture 7B\">",
"      Applying upper arm brace",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29543?source=related_link\">",
"      Proximal humeral fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43812?source=related_link\">",
"      Stress fractures of the humeral shaft",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_55_27511="Approach to the child with bow-legs";
var content_f26_55_27511=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the child with bow-legs",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Scott B Rosenfeld, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27511/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/55/27511/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/55/27511/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bow-legs (genu varum) is an angular deformity at the knee where the apex of the deformity points away from the midline (",
"    <a class=\"graphic graphic_figure graphicRef62835 \" href=\"UTD.htm?42/25/43408\">",
"     figure 1",
"    </a>",
"    ). Knock-knees (genu valgum) are an angular deformity at the knee where the apex of the deformity points toward the midline (",
"    <a class=\"graphic graphic_figure graphicRef62835 \" href=\"UTD.htm?42/25/43408\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Bow-legs and knock-knees are among the most common musculoskeletal anatomic variations encountered by pediatric primary care providers and a common reason for referral to a pediatric orthopedic surgeon. However, most children with bow-legs or knock-knees have variations of normal lower-extremity development that can be monitored by the primary care provider.",
"   </p>",
"   <p>",
"    An understanding of the normal physiologic development of the lower extremity is essential in differentiating physiologic from pathologic alignment. Pathologic causes of bow-legs include Blount disease, nutritional rickets and other metabolic bone diseases, skeletal dysplasia, infection, trauma, and neoplasia. Unlike physiologic bowing, these conditions generally do not improve over time and may require treatment with bracing or surgery.",
"   </p>",
"   <p>",
"    This topic will provide an overview of normal physiologic alignment of the lower extremity, physiologic and pathologic causes of bowing, and an approach to the child with bow-legs. Knock-knees are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6199?source=see_link\">",
"     \"Approach to the child with knock-knees\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL PHYSIOLOGIC ALIGNMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An understanding of normal development of the lower extremity is essential to differentiation of physiologic from pathologic deformities.",
"   </p>",
"   <p>",
"    Lower-extremity alignment goes through a predictable progression from varus (bow-legs) to valgus (knock-knees) over the first seven years of life (",
"    <a class=\"graphic graphic_figure graphicRef74063 \" href=\"UTD.htm?37/33/38417\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53765 \" href=\"UTD.htm?38/10/39085\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/1\">",
"     1",
"    </a>",
"    ]. There is a wide range of normal values [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At birth, normal alignment is varus.",
"     </li>",
"     <li>",
"      As the child begins to stand and walk, the amount of varus often increases. Children who walk at an early age may have greater varus alignment.",
"     </li>",
"     <li>",
"      Around 18 to 24 months of age, alignment should be neutral.",
"     </li>",
"     <li>",
"      After 24 months, alignment should progress to valgus until it reaches a maximum at four years.",
"     </li>",
"     <li>",
"      After age four years, valgus alignment should decrease toward physiologic adult alignment of slight valgus to neutral.",
"     </li>",
"     <li>",
"      By age seven years, a child usually has reached his or her adult lower-extremity alignment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CAUSES OF BOW-LEGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of bow-legs include physiologic bowing, Blount disease, nutritional rickets and other metabolic bone diseases, skeletal dysplasias, trauma, infection, and neoplasia (",
"    <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physiologic varus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal alignment of the lower extremity from birth until 18 to 24 months of age is varus. The majority of young children with bowed legs have physiologic bowing, defined as varus deformity with a tibiofemoral angle that is within two standard deviations from the mean for age. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Normal physiologic alignment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Characteristic features of physiologic bowing include (",
"    <a class=\"graphic graphic_picture graphicRef73946 \" href=\"UTD.htm?34/21/35153\">",
"     picture 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age between birth and two years",
"     </li>",
"     <li>",
"      Bilateral and relatively symmetric deformities",
"     </li>",
"     <li>",
"      Bowing of both femurs and tibias",
"     </li>",
"     <li>",
"      Normal stature (ie, within two standard deviations of the mean for age and sex)",
"     </li>",
"     <li>",
"      No lateral thrust with ambulation; a lateral thrust is a brief lateral knee-joint protrusion during the stance phase of gait that suggests incompetence of the knee ligaments with increased risk of progression (",
"      <a class=\"graphic graphic_figure graphicRef72639 \" href=\"UTD.htm?23/5/23633\">",
"       figure 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Physiologic bowing often is associated with internal tibial torsion, which accentuates the apparent genu varum [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although it is not necessary to obtain radiographs in children with physiologic bowing, radiographic features of physiologic bowing include (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54036 \" href=\"UTD.htm?38/25/39312\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tibial metaphyseal-diaphyseal (MD) angle of &le;11&ordm;",
"     </li>",
"     <li>",
"      Femur MD angles greater than tibial MD angles (ratio of femur MD angle:tibial MD angle &gt;1)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathologic varus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic varus may be caused by Blount disease, systemic disorders (eg, nutritional rickets and other metabolic bone diseases), skeletal dysplasia, or asymmetric growth (eg, following unilateral trauma, infection, or neoplasia) (",
"    <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical and radiographic features distinguish physiologic from pathologic varus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2\">",
"     2",
"    </a>",
"    ]. Clues to pathologic varus include short stature, lateral thrust (",
"    <a class=\"graphic graphic_figure graphicRef72639 \" href=\"UTD.htm?23/5/23633\">",
"     figure 4",
"    </a>",
"    ), asymmetry, and progression rather than improvement between birth and two years (",
"    <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5-8\">",
"     5-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Blount disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blount disease is a pathologic varus deformity that results from disruption of normal cartilage growth at the medial aspect of the proximal tibial physis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57787 \" href=\"UTD.htm?2/9/2193\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/9\">",
"     9",
"    </a>",
"    ]. This may cause severe varus deformity, leg length discrepancy, and articular incongruity.",
"   </p>",
"   <p>",
"    There are two types of Blount disease: infantile and adolescent. Infantile Blount disease typically is diagnosed before four years of age and must be distinguished from physiologic varus; it is usually bilateral (80 percent of cases) and typically worsens after walking has begun [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. Adolescent Blount disease is diagnosed later in childhood and may be unilateral or bilateral [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/10\">",
"     10",
"    </a>",
"    ]. Risk factors for Blount disease include obesity, African-American ethnicity, and early walking [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=see_link&amp;anchor=H24#H24\">",
"     \"Comorbidities and complications of obesity in children and adolescents\", section on 'Tibia vara (Blount disease)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical examination in children with Blount disease may demonstrate asymmetric angular alignment of the lower extremities, focal angulation at the proximal tibia, and lateral thrust (",
"    <a class=\"graphic graphic_figure graphicRef72639 \" href=\"UTD.htm?23/5/23633\">",
"     figure 4",
"    </a>",
"    ) during the stance phase of ambulation. Patients with these characteristics should undergo radiographic examination. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Radiographs'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Radiographic features of Blount disease include varus deformity of the proximal tibia with medial beaking and downward slope of the proximal tibial metaphysis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57787 \" href=\"UTD.htm?2/9/2193\">",
"     image 2",
"    </a>",
"    ). In addition, the proximal tibial metaphyseal-diaphyseal (MD) angle is usually &gt;16&ordm;, although this finding is not diagnostic [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,11,12\">",
"     2,11,12",
"    </a>",
"    ]. The femur MD angle is less than the tibial MD angle (ratio of femur MD angle:tibial MD angle &lt;1).",
"   </p>",
"   <p>",
"    The treatment of Blount disease depends upon the age of the child and the severity of the deformity. Patients with infantile Blount disease may be treated with braces to unload medial compressive forces [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. Brace treatment should be started by three years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/13\">",
"     13",
"    </a>",
"    ]. In observational studies, brace therapy is successful in 50 to 80 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/14\">",
"     14",
"    </a>",
"    ]. If the deformity does not resolve with bracing, surgical therapies include guided growth through hemiepiphysiodesis (arrest of the growth plate on the apical side of the deformity) or tibial osteotomy and realignment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Surgical intervention for infantile Blount disease should be performed before four years of age to reduce the risk of recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bracing is ineffective in the treatment of adolescent Blount disease. Surgical intervention with hemiepiphysiodesis or tibial osteotomy is the mainstay of treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Rickets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rickets is a disorder characterized by deficient bone mineralization (metabolic bone disease). When it has onset before 18 to 24 months of age (eg, nutritional vitamin D deficiency, X-linked hypophosphatemic rickets, Fanconi syndrome) it is associated with genu varum (",
"    <a class=\"graphic graphic_picture graphicRef66400 \" href=\"UTD.htm?5/8/5263\">",
"     picture 2",
"    </a>",
"    ); when it has later onset (ie, during the valgus stage of development around age four years), it is associated with knock-knees [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28248?source=see_link\">",
"     \"Etiology and treatment of calcipenic rickets in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21209?source=see_link\">",
"     \"Hereditary hypophosphatemic rickets and tumor-induced osteomalacia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with rickets usually are of short stature (&lt;10",
"    <sup>",
"     th",
"    </sup>",
"    percentile) and have bilateral, symmetric nonphysiologic bowing of the femurs and tibias [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/7\">",
"     7",
"    </a>",
"    ]. Laboratory abnormalities vary depending upon the underlying disorder. In severe cases, radiographs may show diminished bone density, widened and cupped physes, and flared metaphyses (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59611 \" href=\"UTD.htm?27/39/28287\">",
"     image 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2\">",
"     2",
"    </a>",
"    ]. The absence of these findings on radiographs does not preclude a less severe degree of metabolic bone disease. Rickets deformity may improve with medical treatment. Surgical intervention should be delayed until adequate medical control is achieved [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Skeletal dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal dysplasia (eg, achondroplasia, pseudoachondroplasia, metaphyseal chondrodysplasia) is another cause of bilateral, symmetric bowed legs [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/17\">",
"     17",
"    </a>",
"    ]. Additional features of skeletal dysplasia may include short stature (&lt;5",
"    <sup>",
"     th",
"    </sup>",
"    percentile) and characteristic physical features [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2\">",
"     2",
"    </a>",
"    ]. The clinical features vary depending upon the underlying disorder (",
"    <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"     table 1",
"    </a>",
"    ). Serum calcium and phosphorous concentrations typically are normal in children with skeletal dysplasias [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/7\">",
"     7",
"    </a>",
"    ]. Radiographic features of skeletal dysplasia vary with the site of involvement, which may be principally epiphyseal, physeal, metaphyseal, or diaphyseal, or may involve multiple sites. A skeletal survey, which includes the skull and spine, may be needed to assess a child with suspected skeletal dysplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Asymmetric growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bow-legs also may be caused by asymmetric growth arrest or overgrowth of the distal femur",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    proximal tibia (secondary to infection, fracture, or neoplasia) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. Such deformities are almost always unilateral.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presenting complaints for children with bow-legs may include concerns about appearance of the child's legs, excessive falling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    in-toeing (which is often associated with bow-legs).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is the most important component of the evaluation of the child with bow-legs. Radiographs are necessary in a minority of cases. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Radiographs'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the history in a child with bow-legs include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5-7,15,18\">",
"     5-7,15,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Growth and development",
"     </li>",
"     <li>",
"      Onset (ie, before or after birth? Before or after walking?)",
"     </li>",
"     <li>",
"      Progression (physiologic varus improves with growth; pathologic varus worsens with growth)",
"     </li>",
"     <li>",
"      Associated complaints (pain, limp, tripping, falling, in-toeing)",
"     </li>",
"     <li>",
"      Family history (parents or siblings with similar appearance, short stature, rickets, skeletal dysplasia)",
"     </li>",
"     <li>",
"      Previous treatment (if any) and treatment response",
"     </li>",
"     <li>",
"      Dietary and vitamin intake (particularly calcium and vitamin D)",
"     </li>",
"     <li>",
"      Sunlight exposure",
"     </li>",
"     <li>",
"      History of infection, trauma, or fracture (that may have caused asymmetric growth retardation or stimulation)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is also important to ascertain the parents' perceptions of the deformity and concerns regarding gait, appearance, and function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the physical examination of the child with lower-extremity malalignment include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5-7,15,18\">",
"     5-7,15,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Length/height",
"      </span>",
"      &ndash; The child's length or height should be plotted on the standardized growth curve ((",
"      <a class=\"graphic graphic_figure graphicRef67950 \" href=\"UTD.htm?30/44/31426\">",
"       figure 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef63399 \" href=\"UTD.htm?43/1/44050\">",
"       figure 6",
"      </a>",
"      ) [for boys] and (",
"      <a class=\"graphic graphic_figure graphicRef80511 \" href=\"UTD.htm?29/51/30514\">",
"       figure 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef77249 \" href=\"UTD.htm?29/10/29858\">",
"       figure 8",
"      </a>",
"      ) [for girls]). Lower-extremity malalignment and",
"      <span class=\"nowrap\">",
"       length/height",
"      </span>",
"      less than the 3rd percentile are potential clues to a pathologic condition (eg, rickets, skeletal dysplasia) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/19\">",
"       19",
"      </a>",
"      ]. Less severe short stature (eg, 10th or 25",
"      <sup>",
"       th",
"      </sup>",
"      percentile) may be cause for concern if the child has other manifestations of a pathologic condition associated with bow-legs (",
"      <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathologic varus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Weight &ndash; The child's weight should be measured and body mass index calculated ((",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) [for boys] and (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=see_link\">",
"       calculator 2",
"      </a>",
"      ) [for girls]). Obesity is a risk factor for adolescent Blount disease. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Blount disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=see_link\">",
"       \"Clinical evaluation of the obese child and adolescent\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Focused examination of the lower extremities &ndash; Focused examination of the lower extremities in young children may be easier if performed with the child sitting on the parent's lap.",
"      <br/>",
"      <br/>",
"      With the child in the seated position, the knees should be extended and the legs rotated so that the patellas are pointed straight ahead. This maneuver is necessary to accurately estimate lower-extremity angular alignment because it removes any apparent varus or valgus that may be caused by tibial torsion or femoral anteversion (",
"      <a class=\"graphic graphic_picture graphicRef80754 \" href=\"UTD.htm?42/22/43363\">",
"       picture 3",
"      </a>",
"      ). With the legs held in this position, a gross estimate of the amount of varus can be measured. Greater than 6 cm between the femoral condyles is considered abnormal at any age [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/20\">",
"       20",
"      </a>",
"      ]. This measurement provides a reproducible, objective, nonradiographic method of monitoring progression or improvement of the deformity over multiple clinic visits.",
"      <br/>",
"      <br/>",
"      Additional components of the lower-extremity examination include [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/6\">",
"       6",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Assessment of symmetry (asymmetry or unilateral involvement is suggestive of pathologic genu varum).",
"     </li>",
"     <li>",
"      Assessment of leg length (shortening of the legs may suggest skeletal dysplasia) (",
"      <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"       table 1",
"      </a>",
"      ). Leg-length discrepancy may indicate asymmetric physeal growth.",
"     </li>",
"     <li>",
"      Determination of the site of angulation: femur and tibia (physiologic bowing), knee (ligamentous hyperlaxity), proximal tibial metaphysis with acute medial angulation (Blount disease).",
"     </li>",
"     <li>",
"      Palpation of the epiphyses of the long bones (enlarged in nutritional rickets).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Observation of gait &ndash; If the child is ambulatory, the child's gait should be observed as the child walks toward and away from the examiner [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2\">",
"       2",
"      </a>",
"      ]. The foot progression and patellar progression angles should be noted. These angles describe the alignment of the foot and patella, respectively, as they relate to the direction that the patient is moving. For example, an internal foot progression angle describes a foot that points toward the midline as the patient walks forward. An external patellar progression angle describes a patella that points laterally as the patient walks forward.",
"      <br/>",
"      <br/>",
"      The presence or absence of a lateral thrust during ambulation also should be noted. A lateral thrust is a brief lateral knee-joint protrusion during the stance phase of gait. It suggests incompetence of the knee ligaments and is a clue to pathologic bowing (",
"      <a class=\"graphic graphic_figure graphicRef72639 \" href=\"UTD.htm?23/5/23633\">",
"       figure 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. Lateral thrust may be characteristic of pathologic genu varum but is not seen in all cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients younger than three years and those who fit within the age-appropriate progression of varus (",
"    <a class=\"graphic graphic_figure graphicRef74063 \" href=\"UTD.htm?37/33/38417\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53765 \" href=\"UTD.htm?38/10/39085\">",
"     figure 3",
"    </a>",
"    ) rarely need radiographs. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Normal physiologic alignment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications &ndash; We suggest that radiographs be obtained in children with clinical features suggestive of pathologic varus (",
"      <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,6,15,18\">",
"       2,6,15,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Technique &ndash; Proper radiographic technique is essential to obtaining useful images. If possible, teleograms (the entire lower extremity from the hips to the feet of both lower extremities) should be obtained with the patient standing (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60274 \" href=\"UTD.htm?36/60/37828\">",
"       image 4",
"      </a>",
"      ). The child should stand with the feet in a comfortable position, not squeezed together. Whether or not the child is standing, it is paramount that the patellas (not the feet) are pointing straight ahead. Otherwise, the amount of varus cannot be accurately assessed. Proper positioning permits serial comparison if necessary [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Findings &ndash; Radiographs should be reviewed to [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,6,15\">",
"       2,6,15",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Determine which bones are affected (eg, femur, tibia, or both).",
"     </li>",
"     <li>",
"      Determine which aspects of the bone are involved: bony diaphysis (as in osteogenesis imperfecta, trauma), metaphysis (skeletal dysplasia), physis or growth plate (rickets, skeletal dysplasia), epiphysis (Blount disease, skeletal dysplasia).",
"     </li>",
"     <li>",
"      Determine the tibiofemoral angle (the angle between the long axis of the tibia and the long axis of the femur).",
"     </li>",
"     <li>",
"      Determine the metaphyseal-diaphyseal (MD) angles of the distal femur and proximal tibia, which helps to identify the location and relative severity of the deformity [",
"      <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/11,21,22\">",
"       11,21,22",
"      </a>",
"      ]. A tibial MD angle &gt;16&ordm; is suggestive of Blount disease. A femoral-tibial MD angle ratio &gt;1 is suggestive of physiologic bowing, whereas a femoral-tibial MD angle ratio &lt;1 suggests Blount disease. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Blount disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Additional evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional evaluation may be necessary if radiographs are suggestive of rickets or skeletal dysplasia. The evaluation varies depending upon the suspected condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that children with clinical features suggestive of pathologic varus (",
"    <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"     table 2",
"    </a>",
"    ) be referred to an orthopedic surgeon or other specialist as indicated by the suspected underlying condition (eg, endocrinologist, geneticist) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/15,18\">",
"     15,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Physiologic bowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that patients with physiologic bowing (as defined above (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Physiologic varus'",
"    </a>",
"    above)) be managed with observation and parental reassurance [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/5,15,18,23\">",
"     5,15,18,23",
"    </a>",
"    ]. The natural history of physiologic bowing is spontaneous regression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients should be followed at four- to six-month intervals to ensure resolution [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Orthotics, such as braces, splints, and shoe inserts, are ineffective, unnecessary, and may have negative psychosocial sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/2,15,23,24\">",
"     2,15,23,24",
"    </a>",
"    ]. It is often helpful to emphasize that improvement in physiologic bowing takes longer than improvement in other conditions.",
"   </p>",
"   <p>",
"    It is not uncommon to encounter families in which one of the parents was treated with braces or other devices for an unknown limb problem. It may be helpful to remind the family that the recommendation of observation and reassurance is based upon the current assessment of their child and that it is impossible to be certain exactly what condition the parent or other family member was treated for many years ago.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pathologic bowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of pathologic bowing depends upon the underlying problem. Medical therapy for the primary disease should be optimized if effective medical therapy is available (eg, rickets) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/15\">",
"     15",
"    </a>",
"    ]. Medical management may result in some improvement in lower-extremity alignment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28248?source=see_link\">",
"     \"Etiology and treatment of calcipenic rickets in children\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H6\">",
"     'Blount disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Surgical therapy should be reserved for patients with residual deformity after medical optimization [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/8\">",
"     8",
"    </a>",
"    ]. Surgical therapy for pathologic bowing may include guided growth through hemiepiphysiodesis (arrest of the growth plate on the apical side of the deformity) or tibial osteotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of physiologic bowing is spontaneous correction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pathologic bowing increases the load on the medial compartment of the knee, causing increased laxity of the lateral collateral ligament, lateral thrust, knee instability, and pain [",
"    <a class=\"abstract\" href=\"UTD.htm?26/55/27511/abstract/25\">",
"     25",
"    </a>",
"    ]. Long-term sequelae may include medial meniscal tears and increased risk of osteoarthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lower-extremity alignment goes through a predictable progression from varus (bow-legs) to valgus (knock-knees) over the first seven years of life (",
"      <a class=\"graphic graphic_figure graphicRef74063 \" href=\"UTD.htm?37/33/38417\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53765 \" href=\"UTD.htm?38/10/39085\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Normal physiologic alignment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most young children with bow-legs have physiologic bowing (varus). Physiologic varus is defined by a tibiofemoral angle within two standard deviations of the mean for age. Characteristic features of physiologic varus include age between birth and 2 years, bilateral and relatively symmetric deformities, bowing of both femurs and tibias, normal stature, and no lateral thrust (",
"      <a class=\"graphic graphic_figure graphicRef72639 \" href=\"UTD.htm?23/5/23633\">",
"       figure 4",
"      </a>",
"      ) with ambulation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physiologic varus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pathologic causes of bowing in young children may include Blount disease, nutritional rickets and other metabolic diseases, skeletal dysplasia, and asymmetric growth secondary to trauma, infection, or tumor (",
"      <a class=\"graphic graphic_table graphicRef69378 \" href=\"UTD.htm?10/39/10877\">",
"       table 1",
"      </a>",
"      ). Clinical features suggestive of pathologic varus are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathologic varus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that radiographs be obtained in children with clinical features suggestive of pathologic varus (",
"      <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"       table 2",
"      </a>",
"      ). Radiographs should include both legs, from the hips to the feet, with the child standing and the patellas pointing straight ahead (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60274 \" href=\"UTD.htm?36/60/37828\">",
"       image 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Radiographs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with clinical features suggestive of pathologic varus (",
"      <a class=\"graphic graphic_table graphicRef77010 \" href=\"UTD.htm?1/38/1643\">",
"       table 2",
"      </a>",
"      ) should be referred to an orthopedic surgeon or other specialist as indicated (eg, endocrinologist, geneticist). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Indications for referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The natural history of physiologic bow-legs is spontaneous resolution. We recommend that children with physiologic bow-legs (as defined in the text (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Physiologic varus'",
"      </a>",
"      above)) be managed with observation and parental reassurance (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Orthotics (braces, splints, shoe inserts) are ineffective, unnecessary, and may have negative psychosocial sequelae. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Physiologic bowing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of pathologic bowing depends upon the underlying problem. Medical therapy for the primary disease should be optimized if effective medical therapy is available. Surgical therapy should be reserved for patients with residual therapy after medical optimization. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Pathologic bowing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/1\">",
"      Salenius P, Vankka E. The development of the tibiofemoral angle in children. J Bone Joint Surg Am 1975; 57:259.",
"     </a>",
"    </li>",
"    <li>",
"     Shoenecker PL, Rich MM. The Lower Extremity. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissy RT, Weinstein SL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1158.",
"    </li>",
"    <li>",
"     Stans AA. Osteomyelitis and septic arthritis. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissy RT, Weinstein SL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/4\">",
"      Cheema JI, Grissom LE, Harcke HT. Radiographic characteristics of lower-extremity bowing in children. Radiographics 2003; 23:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/5\">",
"      Kling TF Jr. Angular deformities of the lower limbs in children. Orthop Clin North Am 1987; 18:513.",
"     </a>",
"    </li>",
"    <li>",
"     The knee and leg. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Tachdjian MO (Ed), Appleton &amp; Lange, Stamford, CT 1997. p.87.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/7\">",
"      Greene WB. Genu varum and genu valgum in children: differential diagnosis and guidelines for evaluation. Compr Ther 1996; 22:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/8\">",
"      Scherl SA. Common lower extremity problems in children. Pediatr Rev 2004; 25:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/9\">",
"      Blount WP. Tibia vara: Osteochondrosis deformans tibiae. J Bone Joint Surg 1937; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/10\">",
"      Bradway JK, Klassen RA, Peterson HA. Blount disease: a review of the English literature. J Pediatr Orthop 1987; 7:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/11\">",
"      Feldman MD, Schoenecker PL. Use of the metaphyseal-diaphyseal angle in the evaluation of bowed legs. J Bone Joint Surg Am 1993; 75:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/12\">",
"      Bowen RE, Dorey FJ, Moseley CF. Relative tibial and femoral varus as a predictor of progression of varus deformities of the lower limbs in young children. J Pediatr Orthop 2002; 22:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/13\">",
"      Zionts LE, Shean CJ. Brace treatment of early infantile tibia vara. J Pediatr Orthop 1998; 18:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/14\">",
"      Loder RT, Johnston CE 2nd. Infantile tibia vara. J Pediatr Orthop 1987; 7:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/15\">",
"      Bruce RW Jr. Torsional and angular deformities. Pediatr Clin North Am 1996; 43:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/16\">",
"      Loeffler RD Jr, Sherman FC. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets. Clin Orthop Relat Res 1982; :4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/17\">",
"      Shirley ED, Ain MC. Achondroplasia: manifestations and treatment. J Am Acad Orthop Surg 2009; 17:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/18\">",
"      Sass P, Hassan G. Lower extremity abnormalities in children. Am Fam Physician 2003; 68:461.",
"     </a>",
"    </li>",
"    <li>",
"     Herring JA. Skeletal Dysplasias. In: Tachjidan's Pediatric Orthopaedics, 4th ed, Saunders, Philadelphia 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/20\">",
"      Heath CH, Staheli LT. Normal limits of knee angle in white children--genu varum and genu valgum. J Pediatr Orthop 1993; 13:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/21\">",
"      Levine AM, Drennan JC. Physiological bowing and tibia vara. The metaphyseal-diaphyseal angle in the measurement of bowleg deformities. J Bone Joint Surg Am 1982; 64:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/22\">",
"      McCarthy JJ, Betz RR, Kim A, et al. Early radiographic differentiation of infantile tibia vara from physiologic bowing using the femoral-tibial ratio. J Pediatr Orthop 2001; 21:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/23\">",
"      Greene WB. Genu varum and genu valgum in children. Instr Course Lect 1994; 43:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/24\">",
"      Driano AN, Staheli L, Staheli LT. Psychosocial development and corrective shoewear use in childhood. J Pediatr Orthop 1998; 18:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/55/27511/abstract/25\">",
"      Goldman V, Green DW. Advances in growth plate modulation for lower extremity malalignment (knock knees and bow legs). Curr Opin Pediatr 2010; 22:47.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6285 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-581423BC0D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27511=[""].join("\n");
var outline_f26_55_27511=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL PHYSIOLOGIC ALIGNMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CAUSES OF BOW-LEGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physiologic varus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathologic varus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Blount disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Rickets",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Skeletal dysplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Asymmetric growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Additional evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INDICATIONS FOR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Physiologic bowing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pathologic bowing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6285\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6285|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/25/39312\" title=\"diagnostic image 1\">",
"      Physiologic bowing xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/9/2193\" title=\"diagnostic image 2\">",
"      Blount disease radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/39/28287\" title=\"diagnostic image 3\">",
"      XLH rickets radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/60/37828\" title=\"diagnostic image 4\">",
"      Standing teleogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6285|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/25/43408\" title=\"figure 1\">",
"      Genu varum and valgum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/33/38417\" title=\"figure 2\">",
"      Lower extremity alignment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/10/39085\" title=\"figure 3\">",
"      Tibio-femoral progression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/5/23633\" title=\"figure 4\">",
"      Lateral thrust",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/44/31426\" title=\"figure 5\">",
"      WHO length for age boys 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/1/44050\" title=\"figure 6\">",
"      CDC stature for age boys 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/51/30514\" title=\"figure 7\">",
"      WHO length for age girls 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/10/29858\" title=\"figure 8\">",
"      CDC stature for age girls 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6285|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/21/35153\" title=\"picture 1\">",
"      Physiologic bow-legs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/8/5263\" title=\"picture 2\">",
"      Rickets bow-legs 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/22/43363\" title=\"picture 3\">",
"      Apparent genu varum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6285|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/39/10877\" title=\"table 1\">",
"      Bow-legs DDx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/38/1643\" title=\"table 2\">",
"      Bow-legs red flags",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?35/14/36070?source=related_link\" title=\"calculator 1\">",
"      Calculator: Body Mass Index (BMI) percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?34/60/35782?source=related_link\" title=\"calculator 2\">",
"      Calculator: Body Mass Index (BMI) percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/3/6199?source=related_link\">",
"      Approach to the child with knock-knees",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=related_link\">",
"      Clinical evaluation of the obese child and adolescent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37674?source=related_link\">",
"      Comorbidities and complications of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28248?source=related_link\">",
"      Etiology and treatment of calcipenic rickets in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21209?source=related_link\">",
"      Hereditary hypophosphatemic rickets and tumor-induced osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=related_link\">",
"      Overview of rickets in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_55_27512="Zidovudine: Pediatric drug information";
var content_f26_55_27512=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zidovudine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"    see \"Zidovudine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/25/22933?source=see_link\">",
"    see \"Zidovudine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Retrovir&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F235152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Zidovudine&reg;;",
"     </li>",
"     <li>",
"      AZT&trade;;",
"     </li>",
"     <li>",
"      Novo-AZT;",
"     </li>",
"     <li>",
"      Retrovir&reg;;",
"     </li>",
"     <li>",
"      Retrovir&reg; (AZT&trade;)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiretroviral Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       HIV Agents (Anti-HIV Agents)",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nucleoside Reverse Transcriptase Inhibitor (NRTI)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      HIV infection, treatment",
"     </b>",
"     (DHHS [pediatric], 2012): Use in combination with other antiretroviral agents; standard neonatal doses may be excessive in premature neonates:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature neonates:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &lt;30 weeks: 2 mg/kg/dose every 12 hours; at 4 weeks of age, increase dose to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;30 weeks and &lt;35 weeks: 2 mg/kg/dose every 12 hours; at PNA 15 days, increase dose to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;35 weeks: 4 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &lt;30 weeks: 1.5 mg/kg/dose every 12 hours; at 4 weeks of age, increase dose to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;30 weeks and &lt;35 weeks: 1.5 mg/kg/dose every 12 hours; at PNA 15 days, increase dose to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;35 weeks: 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Full-term neonates:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: 4 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Maternal-fetal HIV transmission, prevention:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     A 6-week course of zidovudine in the neonate is recommended for",
"     <b>",
"      all",
"     </b>",
"     HIV-exposed neonates to prevent perinatal transmission of HIV. In addition, the recommended regimen in the U.S. to prevent perinatal transmission of HIV also includes maternal antepartum oral zidovudine and maternal intrapartum I.V. zidovudine. Use of zidovudine in combination with nevirapine is recommended in the neonate in select situations (eg, infants born to HIV-infected mothers with no antepartum antiretroviral therapy) prior to labor or during labor; or infants born to mothers with only intrapartum antiretroviral therapy) and may be considered in other situations (eg, infants born to mothers with suboptimal viral suppression at delivery; or infants born to mothers with known antiretroviral drug-resistant virus).",
"     <b>",
"      Note:",
"     </b>",
"     Zidovudine dosing should begin as soon as possible after birth (within 6-12 hours after delivery) and continue for the first 6 weeks of life. If neonate is diagnosed as HIV positive, discontinue prevention (prophylaxis) dosing and begin treatment regimen (see above).",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     (DHHS [perinatal], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature neonates (DHHS [pediatric, perinatal], 2012):",
"     <b>",
"      Note:",
"     </b>",
"     Standard neonatal doses may be excessive in premature neonates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &lt;30 weeks: 2 mg/kg/dose every 12 hours; at 4 weeks of age, increase dose to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;30 weeks and &lt;35 weeks: 2 mg/kg/dose every 12 hours; at PNA 15 days, increase dose to 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;35 weeks: 4 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &lt;30 weeks: 1.5 mg/kg/dose every 12 hours; at 4 weeks of age, increase dose to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;30 weeks and &lt;35 weeks: 1.5 mg/kg/dose every 12 hours; at PNA 15 days, increase dose to 2.3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     GA &ge;35 weeks: 3 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Full-term neonates:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Manufacturer&rsquo;s labeling: 2 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     recommendation: 4 mg/kg/dose every 12 hours (DHHS [pediatric, perinatal], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     World Health Organization simplified dosing regimen: For use in low resource settings:",
"     <b>",
"      Note:",
"     </b>",
"     With the WHO regimen, neonates who weigh &gt;3.75 kg at birth will receive a smaller zidovudine dose (compared with the mg/kg/dose method) and infants &lt;3.75 kg will receive a larger zidovudine dose (WHO, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Birth weight &le;2.5 kg: 10 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Birth weight &gt;2.5 kg: 15 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Manufacturer&rsquo;s labeling: 1.5 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     recommendation: 3 mg/kg/dose every 12 hours (DHHS [pediatric, perinatal], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for hematologic toxicity:",
"     </b>",
"     Consider interruption of therapy  for significant anemia (Hgb &lt;7.5 g/dL or &gt;25% decrease from baseline; neonates: HgB &lt; 7 g/dL) and/or significant neutropenia (ANC &lt;750 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or &gt;50% decrease from baseline; neonates ANC &lt; 500 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ) until evidence of bone marrow recovery occurs; once bone marrow recovers, dose may be resumed using appropriate adjunctive therapy (eg, epoetin alfa)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"      see \"Zidovudine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      HIV infection, treatment:",
"     </b>",
"     Use in combination with other antiretroviral agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Infants 4-6 weeks and full-term at birth:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Manufacturer's labeling: Patient weight 4 to &lt;9 kg: 12 mg/kg/dose twice daily or  8 mg/kg/dose 3 times daily;",
"     <b>",
"      Note:",
"     </b>",
"     The 3 times daily dosing is approved  but rarely used in practice (DHHS [pediatric], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     recommendation: 4 mg/kg/dose every 12 hours (DHHS [pediatric], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     : 3 mg/kg/dose every 12 hours (DHHS [pediatric], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Infants &gt;6 weeks, Children, and Adolescents:",
"     <b>",
"      Note:",
"     </b>",
"     Dosage may be calculated by body weight (in kg) or body surface area and should not exceed the recommended adult dose. Doses calculated by body weight may not be the same as those calculated by body surface area.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     BSA-directed dosing: 240 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /dose every 12 hours (maximum single dose: 300 mg) or 160 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /dose every 8 hours (maximum single dose: 200 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Weight-directed dosing:",
"     <b>",
"      Note:",
"     </b>",
"     Three times daily dosing is approved but rarely used in practice (DHHS [pediatric], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;\">",
"     4 to &lt;9 kg: 12 mg/kg/dose twice daily or 8 mg/kg/dose 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;\">",
"     &ge;9 to &lt;30 kg: 9 mg/kg/dose twice daily or 6 mg/kg/dose 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;\">",
"     &ge;30 kg: 300 mg twice daily or 200 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Infants &gt;6 weeks and Children &lt;12 years: 120 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /dose every 6 hours or as a continuous I.V. infusion at 20 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /hour (Briars, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Children &ge;12 years and Adolescents: 1 mg/kg/dose every 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      HIV postexposure prophylaxis:",
"     </b>",
"     Children &ge;12 years and Adolescents: Oral: 300 mg twice daily",
"     <b>",
"      or",
"     </b>",
"     200 mg 3 times daily  (with food) in combination with lamivudine or emtricitabine, with or without a protease inhibitor depending on risk; begin therapy within 2 hours of exposure if possible; continue for four weeks (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Maternal-fetal HIV transmission, prevention:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     A 6-week course of zidovudine in the neonate is recommended for",
"     <b>",
"      all",
"     </b>",
"     HIV-exposed neonates to prevent perinatal transmission of HIV. In addition, the recommended regimen in the U.S. to prevent perinatal transmission of HIV also includes maternal antepartum oral zidovudine and maternal intrapartum I.V. zidovudine. Use of zidovudine in combination with nevirapine is recommended in the neonate in select situations (eg, infants born to HIV-infected mothers with no antepartum antiretroviral therapy) prior to labor or during labor; or infants born to mothers with only intrapartum antiretroviral therapy) and may be considered in other situations (eg, infants born to mothers with suboptimal viral suppression at delivery; or infants born to mothers with known antiretroviral drug-resistant virus).",
"     <b>",
"      Note:",
"     </b>",
"     Zidovudine dosing should begin as soon as possible after birth (within 6-12 hours after delivery) and continue for the first 6 weeks of life. If neonate is diagnosed as HIV positive, discontinue prevention (prophylaxis) dosing and begin treatment regimen (see above).",
"     <b>",
"      Use I.V. route only until oral therapy can be administered",
"     </b>",
"     (DHHS [perinatal], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Infants &lt;6 weeks and full-term at birth:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Manufacturer&rsquo;s labeling: 2 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     recommendation: 4 mg/kg/dose every 12 hours (DHHS [perinatal], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V.:",
"     <b>",
"      Use I.V. route only until oral therapy can be administered:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Manufacturer's labeling: 1.5 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     recommendation: 3 mg/kg/dose every 12 hours (DHHS [pediatric, perinatal], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      HIV infection, treatment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Oral: 300 mg twice daily or 200 mg 3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.V.: 1 mg/kg/dose administered every 4 hours around-the-clock (5-6 doses daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      HIV postexposure prophylaxis:",
"     </b>",
"     Oral: 300 mg twice daily",
"     <b>",
"      or",
"     </b>",
"     200 mg 3 times daily  (with food) in combination with lamivudine or emtricitabine. A third agent may be added for high risk exposures. Therapy should be started within 2 hours of exposure and continued for 4 weeks (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Maternal-fetal HIV transmission, prevention:",
"     </b>",
"     Maternal dose:",
"     <b>",
"      Note:",
"     </b>",
"     Dose adjustment not required in pregnant women. Begin oral therapy with usual recommended doses based on current guidelines. Zidovudine should be administered by continuous I.V. infusion during labor and delivery regardless of antepartum regimen or mode of delivery in women with HIV RNA &ge;400 copies/mL or unknown HIV RNA status. If oral zidovudine was part of the antepartum regimen, discontinue during intrapartum I.V. infusion. Other antiretroviral agents should be continued orally. Zidovudine I.V. is not required in women receiving combination antiretroviral therapy who have HIV RNA &lt;400 copies/mL near delivery (DHHS [perinatal], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     During labor and delivery, administer zidovudine I.V.: 2 mg/kg as loading dose, followed by a continuous I.V. infusion of 1 mg/kg/hour until delivery. For scheduled cesarean delivery, begin I.V. zidovudine 3 hours before surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants &gt;6 weeks, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     The following adjustments have been recommended (Aronoff, 2007):",
"     <b>",
"      Note:",
"     </b>",
"     Renally adjusted dose recommendations are based on oral doses of 160 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /dose every 8 hours and I.V. dose of 120 mg/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     /dose every 6 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;10 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : No adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer 50% of dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Intermittent hemodialysis (IHD):  Administer 50% of dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Peritoneal dialysis (PD): Administer 50% of dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Continuous renal replacement therapy (CRRT): No adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     End-stage renal disease patients (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute) maintained on hemodialysis or peritoneal dialysis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Manufacturer's labeling: 100 mg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     AIDS",
"     <i>",
"      info",
"     </i>",
"     guidelines: 100 mg every 8 hours or 300 mg once daily (DHHS [adult], 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V.: 1 mg/kg/dose every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Continuous renal replacement therapy (CRRT): No adjustment needed (Aronoff, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Specific recommendations currently unknown; dosage reduction may be required; use with caution; monitor for hematologic toxicities frequently.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment for  hematologic toxicity:",
"     </b>",
"     Consider interruption of therapy for significant anemia (Hgb &lt;7.5 g/dL or &gt;25% decrease from baseline) and/or significant neutropenia (ANC &lt;750 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or &gt;50% decrease from baseline) until evidence of bone marrow recovery occurs; once bone marrow recovers, dose may be resumed using appropriate adjunctive therapy (eg, epoetin alfa).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F235125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 100 mg [contains soya lecithin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 10 mg/mL (20 mL) [contains natural rubber/natural latex in packaging]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral: 10 mg/mL (240 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 10 mg/mL (240 mL) [contains sodium benzoate; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Retrovir&reg;: 300 mg [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F235110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Capsule, syrup, tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: May be administered without regard to meals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: Do not administer I.M.; do not administer I.V. push or by rapid infusion; infuse I.V. zidovudine over 1 hour at a final concentration not to exceed 4 mg/mL; I.V. dose may be infused over 30 minutes in neonates",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F235209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Incompatible",
"     </b>",
"     with blood products and protein solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, allopurinol, amifostine, amikacin, amphotericin B, amphotericin B cholesteryl sulfate complex, anidulafungin, aztreonam, cefepime, ceftazidime, cimetidine, cisatracurium, clindamycin, dexamethasone sodium phosphate, dobutamine, docetaxel, dopamine, doripenem, doxorubicin liposome, erythromycin lactobionate, etoposide phosphate, filgrastim, fluconazole, fludarabine, gemcitabine, gentamicin, granisetron, heparin, imipenem/cilastatin, linezolid, lorazepam, melphalan, metoclopramide, morphine, nafcillin, ondansetron, oxacillin, oxytocin, paclitaxel, pantoprazole, pemetrexed, pentamidine, phenylephrine, piperacillin, piperacillin/tazobactam, potassium chloride, ranitidine, remifentanil, sargramostim, teniposide, thiotepa, tobramycin, trimethoprim/sulfamethoxazole, vancomycin, vinorelbine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone, meropenem.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Pantoprazole.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1056070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Store intact vials at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); protect from light. Diluted solution in D",
"     <sub>",
"      5",
"     </sub>",
"     W to &le;4 mg/mL  is physically and chemically stable for 24 hours at room temperature and 48 hours if refrigerated; to minimize the potential for microbial contamination, manufacturer recommends administering diluted I.V. solution within 8 hours if stored at room temperature and within 24 hours if refrigerated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Tablets, capsules, syrup: Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); protect capsules from moisture",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of HIV infection in combination with other antiretroviral agents [Oral: FDA approved in ages &ge;4 weeks and adults; Injection (short-term use): FDA approved in adults] (",
"     <b>",
"      Note:",
"     </b>",
"     HIV regimens consisting of three antiretroviral agents are strongly recommended); chemoprophylaxis to reduce perinatal HIV transmission [Oral, injection: FDA approved in ages 0 days to 6 weeks (postpartum therapy of HIV-1 exposed neonate) and adults (antepartum and intrapartum therapy of HIV-1 infected mother)]; has also been used as HIV postexposure prophylaxis (eg, chemoprophylaxis after occupational exposure to HIV)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F235211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Azidothymidine may be confused with azaTHIOprine, aztreonam",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Retrovir&reg; may be confused with acyclovir, ritonavir",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       AZT is an error-prone abbreviation (mistaken as azathioprine, aztreonam)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F235208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: ECG abnormality (children), edema (children), heart failure (children), left ventricular dilation (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Chills, fatigue, fever (children), headache, insomnia, irritability (children), malaise, nervousness (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (more common in children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, abdominal pain, anorexia, constipation (adults), diarrhea (children), dyspepsia, nausea (more common in adults),  vomiting (more common in adults), weight loss (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Hematuria (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia (more common in neonates), granulocytopenia, macrocytosis (children), neutropenia (children), thrombocytopenia (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatomegaly (children), transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, musculoskeletal pain, myalgia, neuropathy, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reactions, amblyopia, anaphylaxis, angioedema, anxiety, aplastic anemia, back pain, body fat redistribution, cardiomyopathy, confusion, CPK increased, depression, diabetes, dizziness, dyslipidemias, dyspnea, gynecomastia, hearing loss, hemolytic anemia, hepatitis, hepatomegaly with steatosis, immune reconstitution syndrome, insulin resistance, jaundice, lactic acidosis, LDH increased, leukopenia, loss of mental acuity, lymphadenopathy, macular edema, mania, myopathy, myositis, oral mucosa pigmentation, pancreatitis, pancytopenia with marrow hypoplasia, paresthesia, photophobia, pruritus, pure red cell aplasia, rhabdomyolysis, seizure, skin/nail pigmentation changes (blue), Stevens-Johnson syndrome, syncope, taste perversion, toxic epidermal necrolysis, tremor, urticaria, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Life-threatening hypersensitivity to zidovudine or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1056066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with bone marrow compromise or in patients with impaired renal or hepatic function; reduce dosage or interrupt therapy in patients with anemia, granulocytopenia, or myopathy; reduce dosage in patients with severe renal or hepatic impairment. Fat redistribution and accumulation [ie, central obesity, peripheral wasting, facial wasting, breast enlargement, dorsocervical fat enlargement (buffalo hump), and cushingoid appearance] have been observed in patients receiving antiretroviral agents (causal relationship not established).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Immune reconstitution syndrome (an acute inflammatory response to residual or indolent opportunistic infections) may occur in HIV patients during initial treatment with combination antiretroviral agents; this syndrome may require further patient assessment and therapy. Autoimmune disorders (eg, Grave&rsquo;s disease, Guillain-Barr&eacute; syndrome, and polymyositis) have been reported in patients experiencing immune reconstitution; time to onset is variable and may occur many months after antiretroviral treatment is initiated.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use of zidovudine with stavudine is not recommended due to antagonistic effects. Zidovudine should not be used concurrently with combination products that also contain zidovudine as a component (eg, Combivir&reg; or Trizivir&reg;).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1056065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Hematologic toxicity including neutropenia and severe anemia requiring transfusions may occur",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; use with caution in patients with ANC &lt;1000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or hemoglobin &lt;9.5 g/dL; consider interruption of therapy for significant anemia (Hgb &lt;7.5 g/dL or reduction &gt;25% of baseline; neonates: Hgb &lt;7 g/dL) or neutropenia (ANC &lt;750 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or reduction &gt;50% from baseline; neonates ANC &lt;500 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ); use of erythropoietin or filgrastim may be necessary in some patients. Prolonged use of zidovudine may cause myositis and myopathy",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Cases of lactic acidosis, severe hepatomegaly with steatosis, and death have been reported in patients receiving nucleoside analogues",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; most of these cases have been in women; prolonged nucleoside use, obesity, and prior liver disease may be risk factors; use with extreme caution in patients with other risk factors for liver disease; discontinue therapy in patients who develop laboratory or clinical evidence of lactic acidosis or pronounced hepatotoxicity. Concomitant use of combination antiretroviral therapy with interferon alfa (with or without ribavirin) has resulted in hepatic decompensation (with some fatalities) in patients coinfected with HIV and HCV; monitor patients closely, especially for hepatic decompensation, neutropenia, and anemia; consider discontinuation of zidovudine if needed; consider dose reduction or discontinuation of interferon alfa, ribavirin, or both if clinical toxicities, including hepatic decompensation, worsen.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Syrup contains sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; use syrup containing sodium benzoate with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F235195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2A6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F235119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acyclovir-Valacyclovir: May enhance the CNS depressant effect of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clarithromycin: May enhance the myelosuppressive effect of Zidovudine. Clarithromycin may decrease the serum concentration of Zidovudine. Management: Monitor response to zidovudine closely when used with clarithromycin, and consider staggering zidovudine and clarithromycin doses when possible in order to minimize the potential for interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOXOrubicin: May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin may diminish the therapeutic effect of Zidovudine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOXOrubicin (Liposomal): May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin (Liposomal) may diminish the therapeutic effect of Zidovudine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ganciclovir-Valganciclovir: May enhance the adverse/toxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Hematologic toxicity is of specific concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Interferons: May enhance the adverse/toxic effect of Zidovudine. Interferons may decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: May increase the serum concentration of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the serum concentration of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ribavirin: Zidovudine may enhance the adverse/toxic effect of Ribavirin. Specifically, the risk/severity of anemia may be increased.  Management: Due to significantly increased risk of anemia, consider even closer monitoring for anemia than routinely recommended for ribavirin.  Alternative therapies should be considered when clinically possible, particularly for patients with other risk factors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Zidovudine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Rifabutin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Stavudine: Zidovudine may diminish the therapeutic effect of Stavudine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1056084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not significantly affect bioavailability; folate or vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     deficiency increases zidovudine-associated myelosuppression",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F235121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F235135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Zidovudine crosses the placenta and the placenta also metabolizes zidovudine to the active metabolite. No increased risk of overall birth defects has been observed following first trimester exposure according to data collected by the antiretroviral pregnancy registry. The pharmacokinetics of zidovudine are not significantly altered in pregnancy and dosing adjustment is not needed. The DHHS Perinatal HIV Guidelines consider zidovudine the preferred NRTI for use in combination regimens during pregnancy. The use of zidovudine has been shown to reduce the maternal-fetal transmission of HIV by ~70%. Zidovudine should be administered I.V. near delivery regardless of antepartum regimen or mode of delivery in women with HIV RNA &gt;400 copies/mL or unknown HIV RNA status. In HIV-infected mothers not previously on antiretroviral therapy, and who do not need therapy for their own health, treatment may be delayed until after the first trimester; however, earlier initiation of therapy may be more effective in reducing perinatal transmission.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Cases of lactic acidosis/hepatic steatosis syndrome related to mitochondrial toxicity have been reported in pregnant women with prolonged use of nucleoside analogues. It is not known if pregnancy itself potentiates this known side effect; however, women may be at increased risk of lactic acidosis and liver damage. In addition, these adverse events are similar to other rare but life-threatening syndromes which occur during pregnancy (eg HELLP syndrome). Hepatic enzymes and electrolytes should be monitored in women receiving nucleoside analogues and clinicians should watch for early signs of the syndrome. In addition, mitochondrial dysfunction may develop in infants following",
"     <i>",
"      in utero",
"     </i>",
"     exposure.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Regardless of CD4 count or HIV RNA copy number, all HIV-infected pregnant women should receive a combination antepartum antiretroviral (ARV) drug regimen; this includes women who require therapy for their own health, as well as women who do not yet require therapy for their own health. ARV therapy should be started as soon as possible if required for the woman&rsquo;s health. health. Although earlier initiation may be more effective in reducing the perinatal transmission of HIV), also consider maternal conditions (eg, nausea and vomiting) and the potential risks of first trimester fetal exposure for specific agents. Plasma HIV RNA levels should be assessed at ~34-36 weeks gestation in order to help determine mode of delivery. If ARV therapy must be interrupted for &lt;24 hours during the peripartum period, stop then restart all medications simultaneously in order to decrease the chance of developing resistance. Long-term follow-up is recommended for all infants exposed to ARV medications.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Healthcare providers are encouraged to enroll pregnant women exposed to antiretroviral medications in the Antiretroviral Pregnancy Registry (1-800-258-4263 or www.APRegistry.com). Healthcare providers caring for HIV-infected women and their infants may contact the National Perinatal HIV Hotline (888-448-8765) for clinical consultation (DHHS [perinatal], 2012).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1056073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Monitor CD4 percentage (if &lt;5 years of age) or CD4 count (if &ge;5 years of age) at least every 3-4 months (DHHS [pediatric], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prior to initiation of therapy: Genotypic resistance testing, CD4, viral load, CBC with differential, LFTs, BUN, creatinine. At initiation and with any change in treatment regimen: CBC with differential, electrolytes, calcium, phosphate, glucose, LFTs, bilirubin, BUN, creatinine, albumin, total protein, lipid panel, CD4, and viral load. After 4-8 weeks of therapy: CBC with differential, viral load; then every 3-4 months: CBC with differential, electrolytes, glucose, LFTs, bilirubin, BUN, creatinine, CD4, and viral load. Albumin, total protein, calcium, phosphate,  lipid panel, and urinalysis every 6-12 months (DHHS [pediatric], 2012). Monitor for signs of opportunistic infections, hepatotoxicity, anemia, or lactic acidosis.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zidovudine is a thymidine analog that enters the cell and is phosphorylated by cellular kinases to the active metabolite zidovudine triphosphate which serves as an alternative substrate to deoxythymidine triphosphate for incorporation by reverse transcriptase; inhibits HIV viral polymerases and DNA synthesis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1056080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     In general,  pharmacokinetic data for pediatric patients &gt;3 months to 12 years of age are similar to data in adult patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Significant penetration into the CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CSF/plasma ratio:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants 3 months to Children 12 years (n=38): Median: 0.68; range: 0.03-3.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults (n=39): Median: 0.6;  range: 0.04-2.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : 1.6 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 25% to 38%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive first-pass effect; hepatic via glucuronidation to inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: Similar for tablets, capsules, and syrup",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates &lt;14 days: 89%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 14 days to 3 months: 61%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 3 months to Children 12 years: 65%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 64% &plusmn; 10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, terminal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature neonate: 6.3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Full-term neonates: 3.1 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 14 days to 3 months: 1.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 3 months to Children 12 years: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 0.5-3 hours (mean: 1.1 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Within 30-90 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urinary excretion (63% to 95%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 72% to 74% of drug excreted in urine as metabolites and 14% to 18% as unchanged drug",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 45% to 60% excreted in urine as metabolites and 18% to 29% as unchanged drug",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1056072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/25/22933?source=see_link\">",
"      see \"Zidovudine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zidovudine is not a cure for HIV. Notify physician if muscle weakness, shortness of breath, headache, insomnia, signs of infection, unusual bleeding, or rash occur. Take zidovudine every day as prescribed; do not change dose or discontinue without physician's advice. If a dose is missed, take it as soon as possible, then return to normal dosing schedule; if a dose is skipped, do",
"     <b>",
"      not",
"     </b>",
"     double the next dose.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     HIV medications may cause changes in body fat, including an increase in fat in the upper back and neck, breasts, and trunk; a loss of fat from the face, arms, and legs may also occur. Do not take zidovudine (Retrovir&reg;) with other zidovudine-containing medications (eg, Combivir&reg; or Trizivir&reg;)",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1056082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Conversion from oral to I.V. dose: I.V. dose =",
"     <sup>",
"      2",
"     </sup>",
"     /",
"     <sub>",
"      3",
"     </sub>",
"     of the oral dose. Zidovudine-associated reduction in Hgb may occur as early as 2-4 weeks after initiation of therapy; onset of neutropenia usually occurs after 6-8 weeks.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aberg JA, Kaplan JE, Libman H, et al, \"Primary Care Guidelines for the Management of Persons Infected With Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2009, 49(5):651-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27512/abstract-text/19640227/pubmed\" id=\"19640227\" target=\"_blank\">",
"        19640227",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Briars LA, Hilao JJ, and Kraus DM, \"A Review of Pediatric Human Immunodeficiency Virus Infection,\"",
"      <i>",
"       Journal of Pharmacy Practice",
"      </i>",
"      , 2004, 17(6):407-31.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Center for Disease Prevention (CDC), \"Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2005, 54(RR-9):1-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27512/abstract-text/16195697/pubmed\" id=\"16195697\" target=\"_blank\">",
"        16195697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, \"Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents,\" Febuary 12, 2013. Available at",
"      <a href=\"file://www.aidsinfo.nih.gov\" target=\"_blank\">",
"       file://www.aidsinfo.nih.gov",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, \"Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection,\" November 5, 2012. Available at",
"      <a href=\"file://aidsinfo.nih.gov\" target=\"_blank\">",
"       file://aidsinfo.nih.gov",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, \"Recommendations for the Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States,\" July 31, 2012. Available at",
"      <a href=\"file://aidsinfo.nih1.gov\" target=\"_blank\">",
"       file://aidsinfo.nih.gov",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mueller BU, Jacobsen F, Butler KM, et al, \"Combination Treatment With Azidothymidine and Granulocyte Colony-Stimulating Factor in Children With Human Immunodeficiency Virus Infection,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1992, 121(5 Pt 1):797-802.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27512/abstract-text/1279153/pubmed\" id=\"1279153\" target=\"_blank\">",
"        1279153",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Volberding PA, Lagakos SW, Koch MA, et al, \"Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection. A Controlled Trial in Persons With Fewer Than 500 CD4-Positive Cells Per Cubic Millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1990, 322(14):941-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/55/27512/abstract-text/1969115 /pubmed\" id=\"1969115 \" target=\"_blank\">",
"        1969115",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      World Health Organization, \"Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach,&rdquo; 2010. Available at file://www.who.int/hiv/pub/mtct/antiretroviral2010/en/index.html",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13007 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27512=[""].join("\n");
var outline_f26_55_27512=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708846\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235151\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235152\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056074\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445305\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056067\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235125\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235110\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056078\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235209\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056070\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056077\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235211\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235208\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056081\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056066\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056065\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235195\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235119\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056084\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235121\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235135\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056073\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056064\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056080\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056072\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056082\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13007\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13007|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=related_link\">",
"      Zidovudine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/25/22933?source=related_link\">",
"      Zidovudine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_55_27513="Neonatal HSV neck vesicles";
var content_f26_55_27513=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75059%7EPEDS%2F56041%7EPEDS%2F78598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75059%7EPEDS%2F56041%7EPEDS%2F78598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neck vesicles in neonate with herpes simplex virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The early, untreated skin lesions associated with neonatal herpes simplex virus (HSV) infection are characteristically clear vesicles on an erythematous base, often touching or \"kissing,\" or coalesced in groups of vesicles. Culture of the clear fluid aspirated or swabbed from the vesicles will readily grow HSV in 24 to 48 hours, and slides made from cells scraped from the base of the lesion will show HSV viral antigens by direct immunofluorescence assay (DFA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gail J Demmler-Harrison, MD, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neonatal herpes simplex virus scalp vesicles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scalp lesions of neonate with skin, eye, and mouth neonatal herpes simplex virus (HSV)&nbsp;infection associated with fetal scalp monitor. Gram-stained smear and bacterial cultures were negative, and the lesions did not respond to topical and systemic antibiotics. Viral cultures grew HSV type 2, and the lesions responded to intravenous acyclovir.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jane Troendle-Atkins, MD, and Gail J Demmler-Harrison, MD, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eye vesicles in neonate with herpes simplex virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Neonate with herpes simplex virus (HSV) infection of the eye, showing characteristic coalescing vesicles on an erythematous base on eyelid and surrounding skin. Ophthalmologic evaluation of the eye should also be performed to determine if keratitis or keratoconjunctivitis is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jenny Ravenscroft, MD, and Gail J Demmler-Harrison, MD, Department of Pediatrics, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27513=[""].join("\n");
var outline_f26_55_27513=null;
var title_f26_55_27514="JC virus granule cell neuronopathy in PML";
var content_f26_55_27514=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F67660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F67660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    JC virus granule cell neuronopathy in progressive multifocal leukoencephalopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 732px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Types of demyelinating lesions in the cerebellar white matter (WM) and focal cell loss of granule cell neurons (GCNs) in the GC layer (GCL) of patients with progressive multifocal leukoencephalopathy.",
"    <strong>",
"     (A, C, E, G)",
"    </strong>",
"    Double immunohistochemistry (IHC) for myelin and oligodendrocytes (CNPase, brown) and JC virus (JCV) VP1 capsid (PAB597, dark blue), displayed in 25,000,000 pixel pictures of 1 cm",
"    <sup>",
"     2",
"    </sup>",
"    representative portions of cerebellum, shows areas of demyelination and JCV-infected cells (dark blue, marked by arrows in all insets).",
"    <strong>",
"     (B, D, F, H)",
"    </strong>",
"    Double IHC for neurons (NeuN, brown) and JCV VP1 capsid (PAB597, dark blue).",
"    <strong>",
"     (A)",
"    </strong>",
"    Type I, an isolated JCV infected cell is present in the GCL (arrow, inset) in the absence of a PML lesion in the cerebellar WM. This cell is not visible in the adjacent section",
"    <strong>",
"     (B)",
"    </strong>",
"    , which shows an intact GCL.",
"    <strong>",
"     (C)",
"    </strong>",
"    Type II, a small demyelinating lesion at the GCL/WM junction contains JCV-infected cells at the periphery (arrows, inset).",
"    <strong>",
"     (D)",
"    </strong>",
"    The JCV-infected cells are detected in a preserved GCL in the same area.",
"    <strong>",
"     (E)",
"    </strong>",
"    Type III, numerous confluent demyelinating lesions penetrating the GCL harbor JCV-infected cells (arrows, inset), whereas rare JCV-infected cells (arrows, inset) are present in the GCL, which has no to limited focal GCN loss",
"    <strong>",
"     (F)",
"    </strong>",
"    .",
"    <strong>",
"     (G)",
"    </strong>",
"    Type IV, a cavitated PML lesion shows almost complete disappearance of myelin and oligodendrocytes in both the folia and the GCL. Almost all JCV-infected cells disappeared and only rare apoptotic JCV-infected cells or debris of JCV-infected cells (arrows, inset) are still present at the border of the demyelinated areas. These cells and debris are not visible in the inset of the adjacent section",
"    <strong>",
"     (H)",
"    </strong>",
"    , which shows some areas of focal GCN loss (arrowheads, inset).",
"    <div class=\"footnotes\">",
"     CNPase: Monoclonal antibody to cyclic nucleotide phosphodiesterase;&nbsp;IHC: immunohistochemistry; GCL: granule cell layer; GCNs: granule cell neurons; JCV: JC virus; ML: molecular layer;&nbsp;NeuN: Monoclonal antibody to neuronal nuclei; WM: white matter",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wuthrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68:15. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27514=[""].join("\n");
var outline_f26_55_27514=null;
var title_f26_55_27515="Assessment of gestational age";
var content_f26_55_27515=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Assessment of gestational age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Parameter",
"      </td>",
"      <td class=\"subtitle1\">",
"       Gestational age, weeks",
"      </td>",
"      <td class=\"subtitle1\">",
"       Accuracy, days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mean sac diameter",
"      </td>",
"      <td>",
"       4.5 to 6",
"      </td>",
"      <td>",
"       &plusmn; 5 to 7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Crown-rump length",
"      </td>",
"      <td>",
"       7 to 10",
"      </td>",
"      <td>",
"       &plusmn; 3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       10 to 14",
"      </td>",
"      <td>",
"       &plusmn; 5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       15",
"      </td>",
"      <td>",
"       &plusmn; 8.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Biparietal diameter, head circumference, femur length",
"      </td>",
"      <td>",
"       14 to 20",
"      </td>",
"      <td>",
"       &plusmn; 7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       21 to 30",
"      </td>",
"      <td>",
"       &plusmn; 14",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       over 30",
"      </td>",
"      <td>",
"       &plusmn; 21 to 28",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The American College of Obstetricians and Gynecologists suggest using the sonographically derived gestational age to calculate estimated date of delivery (EDD) if it differs from that calculated using the LMP by more than seven days in the first trimester and by more than 10 days in the second trimester but before 20 weeks of gestation. ACOG Practice Bulletin No. 98: Ultrasonography in pregnancy. Obstet Gynecol 2008; 112:951.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27515=[""].join("\n");
var outline_f26_55_27515=null;
var title_f26_55_27516="Techniques of the initial phase of Interpersonal Psychotherapy";
var content_f26_55_27516=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F78732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F78732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Techniques of the initial phase of Interpersonal Psychotherapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Technique",
"       </td>",
"       <td class=\"subtitle1\">",
"        Strategy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnose major depression",
"       </td>",
"       <td>",
"        Conduct psychiatric interview, including current and past psychiatric symptoms, prior treatment history, medical history, and family psychiatric history.",
"       </td>",
"       <td>",
"        Diagnosis is essential to prescribing appropriate treatment. This information is also used to select the IPT problem area.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Give the sick role",
"       </td>",
"       <td>",
"        Assign the patient a temporary social role that relieves him of his usual social obligations because of his medical condition (depression), while requiring him to focus on obligations associated with treatment.",
"       </td>",
"       <td>",
"        The concept of the sick role follows from the medical model in which depression is likened to other medical illness such as diabetes and asthma.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Take an interpersonal inventory",
"       </td>",
"       <td>",
"        Evaluate important interpersonal relationships and recent significant changes that have occurred in these relationships and in psychosocial functioning.",
"       </td>",
"       <td>",
"        The clinician focuses on the quality of current interpersonal relationships and recent changes in the patient's life.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Establish a depression timeline",
"       </td>",
"       <td>",
"        Establish the time of onset of current depressive episode (or exacerbation of depressive symptoms) and temporal relationship between changes in mood and changes in interpersonal functioning.",
"       </td>",
"       <td>",
"        Identifying the temporal relationship between current mood symptoms and onset of interpersonal problem will enable clinician to select a relevant treatment focus.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Select an interpersonal problem area and formulate the case",
"       </td>",
"       <td>",
"        Propose a treatment focus (interpersonal problem area) that links current mood symptoms to affectively meaningful change in life circumstances.",
"       </td>",
"       <td>",
"        Patient must agree to treatment focus; if there is disagreement, clinician revises the treatment formulation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Provide hope",
"       </td>",
"       <td>",
"        Maintain optimism.",
"       </td>",
"       <td>",
"        Providing hope is a nonspecific therapeutic factor that is common across different psychotherapies.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Discuss the treatment contract",
"       </td>",
"       <td>",
"        Negotiate treatment logistics including number of sessions, meeting times, fees, and procedures for managing issues that occur between sessions.",
"       </td>",
"       <td>",
"        The time-limited nature of acute IPT requires that treatment duration be specified from the outset.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27516=[""].join("\n");
var outline_f26_55_27516=null;
var title_f26_55_27517="Thyroid nodules after radiation";
var content_f26_55_27517=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Thyroid nodules in irradiated patients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 290px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Size distribution of 157 thyroid nodules in 47 patients with a history of radiation exposure; seven others had no nodules. Eleven nodules were 1.5 cm or larger, five of which were palpable.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Schneider AB, Bekerman C, Leland J, et al. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation.&nbsp;J Clin Endocrinol Metab 1997; 82:4020.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27517=[""].join("\n");
var outline_f26_55_27517=null;
var title_f26_55_27518="Human genome";
var content_f26_55_27518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Autosomes, sex-chromosomes, mitochondrial genomes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 285px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The human genome is DNA organized as 23 chromosomes including 22 autosomes (named 1-22), and one sex chromosome (either X or Y). Humans are diploid, with each somatic cell consisting of two sets of 23 chromosomes, one paternally inherited (blue) and one maternally inherited (pink). The Y chromosome is necessarily paternally inherited. The mitochondrial genome (mt) is derived solely from mitochondria in the ova and therefore exhibits exclusive matrilineal inheritance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27518=[""].join("\n");
var outline_f26_55_27518=null;
var title_f26_55_27519="Gram stain pleural fluid 1";
var content_f26_55_27519=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain pleural fluid 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_55_27519=[""].join("\n");
var outline_f26_55_27519=null;
